Transform Wealth LLC Reduces Stock Position in The Allstate Co. (NYSE:ALL)

Transform Wealth LLC reduced its holdings in The Allstate Co. (NYSE:ALL) by 6.3% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,725 shares of the insurance provider’s stock after selling 587 shares during the period. Transform Wealth LLC’s holdings in Allstate were worth $1,518,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. SageView Advisory Group LLC purchased a new position in shares of Allstate in the 4th quarter worth $456,000. Rafferty Asset Management LLC grew its stake in shares of Allstate by 5.7% in the 4th quarter. Rafferty Asset Management LLC now owns 92,753 shares of the insurance provider’s stock worth $12,984,000 after buying an additional 4,987 shares in the last quarter. Ellsworth Advisors LLC purchased a new position in shares of Allstate during the 4th quarter worth about $4,312,000. SteelPeak Wealth LLC boosted its stake in shares of Allstate by 175.2% during the 4th quarter. SteelPeak Wealth LLC now owns 15,682 shares of the insurance provider’s stock worth $2,209,000 after purchasing an additional 9,984 shares during the period. Finally, Lighthouse Investment Partners LLC purchased a new position in shares of Allstate during the 4th quarter worth about $5,927,000. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate Stock Up 1.1 %

Shares of NYSE ALL traded up $1.68 during trading hours on Thursday, hitting $160.04. 1,222,197 shares of the stock were exchanged, compared to its average volume of 1,595,374. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.48. The company has a market cap of $42.24 billion, a PE ratio of 35.21, a PEG ratio of 1.90 and a beta of 0.50. The firm has a fifty day moving average price of $166.32 and a 200-day moving average price of $159.84. The Allstate Co. has a 12 month low of $100.57 and a 12 month high of $177.37.

Allstate (NYSE:ALL) last posted its quarterly earnings data on Thursday, May 2nd. The insurance provider reported $5.13 EPS for the quarter, topping the consensus estimate of $4.11 by $1.02. The firm had revenue of $15.26 billion during the quarter, compared to analyst estimates of $12.76 billion. Allstate had a net margin of 2.31% and a return on equity of 14.44%. Allstate’s revenue was up 10.7% on a year-over-year basis. During the same quarter in the previous year, the business posted ($1.30) EPS. On average, sell-side analysts expect that The Allstate Co. will post 12.15 EPS for the current year.

Allstate Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Friday, May 31st will be paid a dividend of $0.92 per share. The ex-dividend date of this dividend is Friday, May 31st. This represents a $3.68 annualized dividend and a dividend yield of 2.30%. Allstate’s dividend payout ratio (DPR) is presently 81.24%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on ALL shares. Evercore ISI lifted their price target on shares of Allstate from $166.00 to $173.00 and gave the stock an “in-line” rating in a research note on Thursday, April 11th. The Goldman Sachs Group lifted their price target on shares of Allstate from $164.00 to $195.00 and gave the stock a “buy” rating in a research note on Monday, March 25th. StockNews.com cut shares of Allstate from a “strong-buy” rating to a “buy” rating in a research note on Monday, June 3rd. Morgan Stanley lifted their price target on shares of Allstate from $187.00 to $190.00 and gave the stock an “overweight” rating in a research note on Monday, April 15th. Finally, Roth Mkm boosted their price objective on shares of Allstate from $175.00 to $200.00 and gave the company a “buy” rating in a research report on Monday, April 8th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $174.88.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.